Pvh Corp.
$5.05B- Market cap
- $3.43B
- Debt
- +$2.32B
- Cash
- −$701.50M
Capital structure 60% equity / 40% debt · EV / Revenue 0.56x · EV / EBITDA 10.04x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $3.43B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2026 ·
Decision snapshot: PVH stock price at premium vs PAHC $74.35 current versus $8.19 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PAHC's multiple
Implied fair value · at PVH's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PVH FY 2026 (ended Feb 1, 2026) · PAHC FY 2026 (ended Jun 30, 2026). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 60% equity / 40% debt · EV / Revenue 0.56x · EV / EBITDA 10.04x
Capital structure 73% equity / 27% debt · EV / Revenue 2.31x · EV / EBITDA 15.03x
PVH carries the larger enterprise value at $5.05B against $3.51B; PVH trades on the lower EV / Revenue multiple (0.56x vs 2.31x); PVH on the lower EV / EBITDA (10.04x vs 15.03x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
PVH CORP. · implied price per share
Bear
$67.33
Base
$85.11
Bull
$108.27
Phibro Animal Health Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.48x
2.47x
Net debt / EBITDA
Leverage against operating earnings
3.21x
3.73x
Cash and equivalents
Liquid reserves on the balance sheet
$701.50M
$81.99M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$2.32B
$951.75M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.